Association Between Systemic Neuroinflammation, Pain Perception and Clinical Status in Fibromyalgia Patients: Cross-Sectional Study
Authors:
- María Elena González-ÁlvarezMGMaría Elena González-Álvarez
- Víctor Riquelme-AguadoVíctor Riquelme-Aguado
- Ángela González-PérezÁGÁngela González-Pérez
- Rosa Murillo-LlergoRMRosa Murillo-Llergo
- María Manjón-OlmedillasMMMaría Manjón-Olmedillas
- Silvia TurroniSilvia Turroni
- Giacomo RossettiniGRGiacomo Rossettini
- Jorge Hugo VillafañeJorge Hugo Villafañe
Open Access
Abstract
Background: Fibromyalgia (FM) is characterized by chronic pain and a complex array of symptoms, with neuroinflammation implicated in its pathophysiology. Methods: This study aimed to explore the association between neuroinflammation, measured through interleukin levels (IL-1, IL-6, IL-8), and clinical outcomes in FM patients. Using a cross-sectional study design, blood levels of these interleukins were correlated with pain severity and disability, assessed via the Fibromyalgia Impact Questionnaire (FIQ) and pain measures. Results: Results indicated that IL-6 and IL-8 may particularly serve as biomarkers for pain severity and disability in FM patients, showing significant associations with worse clinical outcomes. Elevated IL-8 levels, for instance, correlated strongly with increased pain perception and higher disability scores. Conclusions: These findings suggest that specific interleukins are not only elevated in FM but are actively involved in the modulation of pain and disability, underscoring the role of systemic neuroinflammation in the clinical severity of FM. This study contributes to a deeper understanding of the inflammatory mechanisms in FM and underscores the potential of targeting interleukins in therapeutic strategies.Keywords
This publication has 48 references indexed in Scilit:
- Body perception distortions correlate with neuropathic features in Italian fibromyalgic patients: Findings from a self-administered online surveyMusculoskeletal Science and Practice, 2022
- Neuropathic pain and symptoms of potential small-fiber neuropathy in fibromyalgic patients: A national on-line surveyJoint Bone Spine, 2021
- Interleukin-8 as a therapeutic target for chronic low back pain: Upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse modelEBioMedicine, 2019
- Role of inflammation in the pathogenesis and treatment of fibromyalgiaRheumatology International, 2019
- Brain glial activation in fibromyalgia – A multi-site positron emission tomography investigationBrain, Behavior, and Immunity, 2019
- Osteoarthritis: a call for research on central pain mechanism and personalized prevention strategiesClinical Rheumatology, 2018
- IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patientsJournal of Neuroimmunology, 2016
- Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRISeminars in Arthritis and Rheumatism, 2014
- Evidence of central inflammation in fibromyalgia — Increased cerebrospinal fluid interleukin-8 levelsJournal of Neuroimmunology, 2012
- Short-Term Effects of Neurodynamic Mobilization in 15 Patients With Secondary Thumb Carpometacarpal OsteoarthritisJournal of Manipulative and Physiological Therapeutics, 2011